Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
-13.83%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$49B
AUM Growth
-$8.48B
(-15%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
14.83%
Holding
3,053
New
271
Increased
1,095
Reduced
1,170
Closed
158
Top Buys
| 1 |
Realty Income
O
|
+$93.5M |
| 2 |
VICI Properties
VICI
|
+$72.8M |
| 3 |
Walt Disney
DIS
|
+$71.9M |
| 4 |
W.P. Carey
WPC
|
+$56.2M |
| 5 |
Microsoft
MSFT
|
+$53.9M |
Top Sells
| 1 |
AT&T
T
|
+$98.8M |
| 2 |
Pfizer
PFE
|
+$79.6M |
| 3 |
Corteva
CTVA
|
+$76.2M |
| 4 |
WRK
WestRock Company
WRK
|
+$56.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$50.5M |
Sector Composition
| 1 | Technology | 18.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.6% |
| 4 | Real Estate | 9.33% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Inovio Pharmaceuticals
INO
$146M
| $35K | ﹤0.01% |
1,733
| – | – |
|
2652
ARS Pharmaceuticals
SPRY
$1.02B
| $35K | ﹤0.01% |
+8,412
| New | +$35K |
|
2653
Stock Yards Bancorp
SYBT
$2.29B
| $33K | ﹤0.01% |
+554
| New | +$33K |
|
|
JBIO
2654
Jade Biosciences, Inc. Common Stock
JBIO
$249M
| $32K | ﹤0.01% |
+59
| New | +$32K |
|
2655
Design Therapeutics
DSGN
$378M
| $32K | ﹤0.01% |
+2,344
| New | +$32K |
|
2656
Editas Medicine
EDIT
$248M
| $32K | ﹤0.01% |
+2,718
| New | +$32K |
|
|
BNT
2657
Brookfield Wealth Solutions Ltd.
BNT
$18.8B
| $32K | ﹤0.01% |
+731
| New | +$32K |
|
2658
American Coastal Insurance
ACIC
$539M
| $31K | ﹤0.01% |
20,979
-2,512
| -11% | -$3.71K |
|
2659
Gossamer Bio
GOSS
$630M
| $31K | ﹤0.01% |
3,798
-36,804
| -91% | -$300K |
|
2660
News Corp Class B
NWS
$18.3B
| $30K | ﹤0.01% |
1,929
+221
| +13% | +$3.44K |
|
2661
PMV Pharmaceuticals
PMVP
$84.8M
| $30K | ﹤0.01% |
+2,141
| New | +$30K |
|
2662
Silicom
SILC
$98.9M
| $30K | ﹤0.01% |
897
-2,026
| -69% | -$67.8K |
|
|
FENG
2663
Phoenix New Media
FENG
$29.8M
| $29K | ﹤0.01% |
6,273
-2,382
| -28% | -$11K |
|
2664
The GEO Group
GEO
$3.05B
| $29K | ﹤0.01% |
4,550
-176,664
| -97% | -$1.13M |
|
2665
Trustmark
TRMK
$2.41B
| $29K | ﹤0.01% |
+1,012
| New | +$29K |
|
|
WSR
2666
Whitestone REIT
WSR
$654M
| $29K | ﹤0.01% |
+2,781
| New | +$29K |
|
2667
Assertio
ASRT
$76.9M
| $28K | ﹤0.01% |
+9,750
| New | +$28K |
|
2668
Geron
GERN
$868M
| $28K | ﹤0.01% |
18,187
-8,694
| -32% | -$13.4K |
|
2669
MiMedx Group
MDXG
$1.05B
| $28K | ﹤0.01% |
+8,300
| New | +$28K |
|
2670
Stoke Therapeutics
STOK
$1.21B
| $28K | ﹤0.01% |
+2,170
| New | +$28K |
|
2671
Century Therapeutics
IPSC
$43.4M
| $27K | ﹤0.01% |
+3,308
| New | +$27K |
|
2672
Atea Pharmaceuticals
AVIR
$251M
| $26K | ﹤0.01% |
3,603
-5,939
| -62% | -$42.9K |
|
2673
Fortress Biotech
FBIO
$107M
| $26K | ﹤0.01% |
2,080
| – | – |
|
2674
Synchronoss Technologies
SNCR
$65.4M
| $26K | ﹤0.01% |
2,556
-3,506
| -58% | -$35.7K |
|
|
SQZ
2675
DELISTED
SQZ Biotechnologies Company
SQZ
| $26K | ﹤0.01% |
+8,192
| New | +$26K |
|